What is the recommended treatment for anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anaphylaxis Treatment Protocol

Epinephrine is the first-line and most critical treatment for anaphylaxis and should be administered immediately upon recognition of symptoms. 1, 2

First-Line Treatment

  • Epinephrine dosing:

    • Adults and children ≥30 kg: 0.3-0.5 mg (0.3-0.5 mL of 1:1000 concentration)
    • Children <30 kg: 0.01 mg/kg up to maximum 0.3 mg (0.01 mL/kg of 1:1000 concentration)
    • Route: Intramuscular injection into the anterolateral thigh 1
  • Epinephrine should be given immediately without delay, as delayed administration is associated with increased mortality 3

Adjunctive Therapies

After administering epinephrine, the following adjunctive treatments should be considered:

  1. H1 antihistamines (e.g., diphenhydramine 25-50 mg) for cutaneous symptoms 1
  2. H2 blockers (e.g., famotidine 20 mg IV) for urticaria 1
  3. Albuterol 2.5-5 mg via nebulizer for persistent bronchospasm 1
  4. Systemic glucocorticosteroids (e.g., methylprednisolone 1-2 mg/kg IV every 6 hours or prednisone 0.5 mg/kg orally) to prevent protracted or biphasic reactions 1

Supportive Care

  • Positioning: Place patients with hypotension in supine position with legs elevated or Trendelenburg position for severe hypotension 1
  • Fluid resuscitation: Administer 1-2 liters of normal saline at 5-10 mL/kg in the first 5 minutes for hypotensive patients 1
  • Oxygen: Provide supplemental oxygen for patients with respiratory symptoms or those receiving multiple doses of epinephrine 1
  • Monitoring: Continuous monitoring of vital signs including blood pressure, heart rate, and oxygen saturation 1

Monitoring and Observation

  • Observe patients for at least 4-6 hours after initial symptoms resolve 1
  • High-risk patients (severe initial reaction, required >1 dose of epinephrine, wide pulse pressure, unknown trigger) should have extended observation up to 6 hours or longer, including possible hospital admission 1
  • Low-risk patients may be discharged after 1-hour asymptomatic observation 1
  • Be prepared to administer a second dose of epinephrine if symptoms persist or recur (6-19% of pediatric patients require a second dose) 1

Patient Education and Follow-up

  • Educate patients on recognizing anaphylaxis symptoms and proper use of epinephrine auto-injectors 1
  • Prescribe epinephrine auto-injectors to patients with history of anaphylaxis 1, 4
  • Refer patients to an allergist/immunologist for identification of triggers and long-term management 1
  • Emphasize the importance of activating emergency services (calling 911) during anaphylactic episodes 1

Common Pitfalls to Avoid

  1. Delayed epinephrine administration - This is the most critical error and can be fatal 5
  2. Relying solely on antihistamines - These are adjunctive treatments only and do not replace epinephrine 3
  3. Inadequate observation period - Biphasic reactions can occur hours after initial symptoms resolve 1
  4. Improper route of administration - Intramuscular route in the anterolateral thigh is preferred over subcutaneous for faster absorption 1, 4
  5. Insufficient patient education - Patients must understand when and how to use epinephrine auto-injectors 1

Remember that anaphylaxis is a clinical diagnosis based on symptoms and does not require laboratory confirmation before initiating treatment 6. Early recognition and prompt epinephrine administration are the cornerstones of effective management.

References

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anaphylaxis: Emergency Department Treatment.

Immunology and allergy clinics of North America, 2023

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Research

Anaphylaxis: acute treatment and management.

Chemical immunology and allergy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.